|
1
|
BB Biotech
Schaffhausen,
Switzerland
|
$117M
|
+$8.81M
|
+389,363
|
+6%
|
|
|
2
|
State Street
Boston,
Massachusetts
|
$65.1M
|
+$17.9M
|
+792,393
|
+28%
|
|
|
3
|
HealthCor Management
New York
|
$63.8M
|
+$35.3M
|
+1,559,580
|
+77%
|
|
|
4
|
Vanguard Group
Malvern,
Pennsylvania
|
$63.6M
|
+$1.21M
|
+53,281
|
+2%
|
|
|
5
|
|
$58.8M
|
+$792K
|
+35,014
|
+1%
|
|
|
6
|
Wellington Management Group
Boston,
Massachusetts
|
$51M
|
+$9.54M
|
+421,451
|
+17%
|
|
|
7
|
T. Rowe Price Associates
Baltimore,
Maryland
|
$44.8M
|
-$37M
|
-1,634,754
|
-39%
|
|
|
8
|
Millennium Management
New York
|
$38.5M
|
+$38.3M
|
+1,695,068
|
+363%
|
|
|
9
|
Farallon Capital Management
San Francisco,
California
|
$36.4M
|
-$46.2M
|
-2,043,151
|
-50%
|
|
|
10
|
Citadel Advisors
Miami,
Florida
|
$31.3M
|
+$12.9M
|
+571,747
|
+48%
|
|
|
11
|
Rock Springs Capital Management
Baltimore,
Maryland
|
$22.6M
|
+$3.22M
|
+142,500
|
+13%
|
|
|
12
|
Fidelity Investments
Boston,
Massachusetts
|
$20.8M
|
-$29.3M
|
-1,295,224
|
-53%
|
|
|
13
|
Point72 Asset Management
Stamford,
Connecticut
|
$17.8M
|
-$4.35M
|
-192,196
|
-16%
|
|
|
14
|
OppenheimerFunds
New York
|
$14.8M
|
-$4.07K
|
-180
|
-0%
|
|
|
15
|
|
$13.6M
|
–
|
–
|
–
|
|
|
16
|
|
$13.6M
|
+$6.4M
|
+282,969
|
+59%
|
|
|
17
|
Artisan Partners
Milwaukee,
Wisconsin
|
$13.1M
|
+$11.5M
|
+506,383
|
+221%
|
|
|
18
|
Armistice Capital
New York
|
$11.7M
|
+$14.9M
|
+658,000
|
New
|
|
|
19
|
|
$11.7M
|
+$14.8M
|
+653,993
|
+83,631%
|
|
|
20
|
Bank of New York Mellon
New York
|
$11M
|
-$1.81K
|
-80
|
-0%
|
|
|
21
|
Hudson Bay Capital Management
Stamford,
Connecticut
|
$10.5M
|
+$7.95M
|
+351,600
|
+147%
|
|
|
22
|
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$9.81M
|
+$3.51M
|
+155,351
|
+39%
|
|
|
23
|
Eversept Partners
New York
|
$9.42M
|
+$1.37M
|
+60,411
|
+13%
|
|
|
24
|
Man Group
London,
United Kingdom
|
$8.83M
|
+$8.74M
|
+386,437
|
+353%
|
|
|
25
|
Northern Trust
Chicago,
Illinois
|
$8.76M
|
+$275K
|
+12,176
|
+3%
|
|
